var path='https://www.tickertech.net'; function heading(heading) { document.write('
'+heading+' |
'+ ''+ ' |
'); } function hiLite(imgDocID,imgObjName) { document.images[imgDocID].src = eval(imgObjName + ".src"); } function showStatus(toshow) { window.status = toshow; } function checkChoose() { if (document.choose.ticker.value == "") { alert("Please enter symbols before clicking the go button"); return false; } else return true; } function popJT(url,name){ var xwid = screen.width; xwid = xwid - 10; javaticker = window.open(url,name,'width='+xwid+',height=100,resizable=yes,scrollbars=no,toolbar=no,location=no,directories=no,status=yes,menubar=no'); javaticker.opener.name="opener"; //javaticker.moveTo(0,30); } var allow = 0; var ref = ""+location; if ((ref.indexOf("cryptocurrencieschannel.com") > 0) || (ref.indexOf("cefchannel.com") > 0) || (ref.indexOf("bdcinvestor.com") > 0) || (ref.indexOf("tickertech.com") > 0) || (ref.indexOf("xxxx:") > 0) || (ref.indexOf("javascript:") > 0) || (ref.indexOf("filseclab.com") > 0) || (ref.indexOf("msnscache.com") > 0) || (ref.indexOf("toolbar.google.com") > 0) || (ref.indexOf("etfchannel.com") > 0) || (ref.indexOf("marketnewsvideo.com") > 0) || (ref.indexOf("news.google.com") > 0) || (ref.indexOf("dividendchannel.com") > 0) || (ref.indexOf("www.google.com") > 0) || (ref.indexOf("energystockchannel.com") > 0) || (ref.indexOf("metalschannel.com") > 0) || (ref.indexOf("portfoliochannel.com") > 0) || (ref.indexOf("canadastockchannel.com") > 0) || (ref.indexOf("theonlineinvestor.com") > 0) || (ref.indexOf("investhelp.com") > 0) || (ref.indexOf("preferredstockchannel.com") > 0) || (ref.indexOf("stockoptionschannel.com") > 0) || (ref.indexOf("holdingschannel.com") > 0) || (ref.indexOf("tickertech.net") > 0) || (ref.indexOf("historicalstockprice.com") > 0) || (ref.indexOf("splithistory.com") > 0) || (ref.indexOf("stocksplithistory.com") > 0) || (ref.indexOf("google.c") > 0) || (ref.indexOf("208.71.46.190") > 0) || (ref.indexOf("search.yahoo") > 0) || (ref.indexOf("sharesoutstandinghistory.com") > 0) || (ref.indexOf("marketcaphistory.com") > 0) || (ref.indexOf("ytdreturn.com") > 0) || (ref.indexOf("averageannualreturn.com") > 0) || (ref.indexOf("redinews.com") > 0) || (ref.indexOf("technicalanalysischannel.com") > 0) || (ref.indexOf("stockdma.com") > 0) || (ref.indexOf("stockrsi.com") > 0) || (ref.indexOf("stockmacd.com") > 0) || (ref.indexOf("topdividends.com") > 0) || (ref.indexOf("monthlydividendpayingstocks.com") > 0) || (ref.indexOf("nextearningsdate.com") > 0) || (ref.indexOf("pastearnings.com") > 0) || (ref.indexOf("historicalperatio.com") > 0) || (ref.indexOf("historicalearnings.com") > 0) || (ref.indexOf("webcache.googleusercontent.com") > 0)) { allow = 1; } function ShowTTIPage() { if (allow) { document.write('\n'); } if (allow) { document.write('
\n'); } if (allow) { document.write('5/2 - 7:02 AM \; \; | \n'); } if (allow) { document.write('Kymera Therapeutics Announces First Quarter 2024 Financial Results and Provides a Business Update | \n'); } if (allow) { document.write('
4/25 - 7:00 AM \; \; | \n'); } if (allow) { document.write('Kymera Therapeutics to Report First Quarter 2024 Financial Results on May 2 | \n'); } if (allow) { document.write('
4/8 - 7:02 AM \; \; | \n'); } if (allow) { document.write('Kymera Therapeutics Announces Scientific Presentations at the American Association for Cancer Research 2024 Annual Meeting | \n'); } if (allow) { document.write('
3/8 - 10:00 AM \; \; | \n'); } if (allow) { document.write('Kymera Therapeutics Presents Preclinical Data for STAT6 and TYK2 First-In-Class, Oral Degrader Immunology Programs at the American Academy of Dermatology Annual Meeting | \n'); } if (allow) { document.write('
2/28 - 7:03 AM \; \; | \n'); } if (allow) { document.write('Kymera Therapeutics to Participate in Upcoming March Investor Conferences | \n'); } if (allow) { document.write('
2/22 - 7:00 AM \; \; | \n'); } if (allow) { document.write('Kymera Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results and Provides a Business Update | \n'); } if (allow) { document.write('
2/15 - 7:00 AM \; \; | \n'); } if (allow) { document.write('Kymera Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results on February 22 | \n'); } if (allow) { document.write('
1/31 - 7:00 AM \; \; | \n'); } if (allow) { document.write('Kymera Therapeutics to Present in Fireside Chat at the Guggenheim Healthcare Conference | \n'); } if (allow) { document.write('
1/9 - 9:17 AM \; \; | \n'); } if (allow) { document.write('Kymera Therapeutics Outlines Key 2024 Objectives and Strategy to Progress Leading Portfolio of Immunology and Oncology Programs | \n'); } if (allow) { document.write('
1/9 - 9:15 AM \; \; | \n'); } if (allow) { document.write('Kymera Therapeutics Announces Closing of Upsized $275 Million Public Offering and Full Exercise of Underwriters\' Option to Purchase Additional Shares | \n'); } if (allow) { document.write('
1/5 - 6:00 AM \; \; | \n'); } if (allow) { document.write('Kymera Therapeutics Announces Pricing of $275 Million Public Offering | \n'); } if (allow) { document.write('
1/4 - 4:01 PM \; \; | \n'); } if (allow) { document.write('Kymera Therapeutics Announces Proposed Public Offering | \n'); } if (allow) { document.write('
1/4 - 7:00 AM \; \; | \n'); } if (allow) { document.write('R&D Day Highlights Kymera\'s Immunology Strategy and Emerging Pipeline of Novel, First-in-Class Oral Degraders Addressing Multiple Highly Prevalent Immuno-inflammatory Diseases | \n'); } if (allow) { document.write('
1/2 - 7:00 AM \; \; | \n'); } if (allow) { document.write('Kymera Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference on Tuesday, January 9, 2024 | \n'); } if (allow) { document.write('
\n'); } if (allow) { document.write(' |